SMLR · As filed with the SEC
Semler Scientific balance sheet, by fiscal year
The statement as Semler Scientific presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Balance Sheets · USD
| USD | FY2024 Dec 31, 2024 | FY2023 Dec 31, 2023 | FY2022 Dec 31, 2022 | FY2021 Dec 31, 2021 | FY2020 Dec 31, 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets: | |||||
| Cash and cash equivalents | 8,819,000 | 57,200,000 | 23,014,000 | 37,323,000 | 22,079,000 |
| Restricted cash | 133,000 | 132,000 | — | — | — |
| Short-term investments | — | — | 20,073,000 | — | — |
| Trade accounts receivable, net of allowance for credit losses of $199 and $287, respectively | 4,378,000 | 6,125,000 | 3,884,000 | 3,619,000 | 2,808,000 |
| Short-term notes held for investment | 6,100,000 | — | — | — | — |
| Inventory, net | 358,000 | 445,000 | 469,000 | 550,000 | 340,000 |
| Prepaid expenses and other current assets | 2,900,000 | 2,042,000 | 1,468,000 | 4,044,000 | 1,376,000 |
| Total current assets | 22,688,000 | 65,944,000 | 48,908,000 | 45,536,000 | 26,603,000 |
| Assets for lease, net | 1,423,000 | 2,285,000 | 2,478,000 | 1,643,000 | 1,941,000 |
| Property and equipment, net | 487,000 | 720,000 | 667,000 | 394,000 | 261,000 |
| Long-term investments | 512,000 | 512,000 | 821,000 | 821,000 | 3,051,000 |
| Notes held for investment | — | 5,372,000 | 4,679,000 | — | — |
| Intangible digital assets | 214,633,000 | — | — | — | — |
| Other non-current assets | 85,000 | 270,000 | 2,842,000 | 332,000 | 418,000 |
| Deferred tax assets | — | 2,962,000 | 2,298,000 | 1,946,000 | 2,365,000 |
| Total assets | 239,828,000 | 78,065,000 | 62,693,000 | 50,672,000 | 34,639,000 |
| Liabilities and Stockholders' Equity | |||||
| Current liabilities: | |||||
| Accounts payable | 140,000 | 402,000 | 835,000 | 443,000 | 677,000 |
| Accrued expenses | 5,173,000 | 4,502,000 | 4,748,000 | 3,436,000 | 2,798,000 |
| Deferred revenue | 774,000 | 1,120,000 | 1,160,000 | 921,000 | 963,000 |
| Other short-term liabilities | 226,000 | 176,000 | 114,000 | 80,000 | 76,000 |
| Total current liabilities | 6,313,000 | 6,200,000 | 6,857,000 | 4,880,000 | 4,514,000 |
| Long-term liabilities: | |||||
| Deferred tax liability | 2,765,000 | — | — | — | — |
| Other long-term liabilities | — | 70,000 | 160,000 | 245,000 | 332,000 |
| Total long-term liabilities | 2,765,000 | 70,000 | 160,000 | 245,000 | 332,000 |
| Stockholders' equity: | |||||
| Common stock, $0.001 par value; 50,000,000 shares authorized; 9,770,908 and 7,099,441 shares issued, and 9,556,486 and 6,885,019 shares outstanding (treasury shares of 214,422 and 214,422), respectively | 9,000 | 7,000 | 7,000 | 7,000 | 7,000 |
| Additional paid-in capital | 130,039,000 | 11,985,000 | 16,449,000 | 20,645,000 | 22,113,000 |
| Retained earnings | 100,702,000 | 59,803,000 | 39,220,000 | 24,895,000 | 7,673,000 |
| Total stockholders' equity | 230,750,000 | 71,795,000 | 55,676,000 | 45,547,000 | 29,793,000 |
| Total liabilities and stockholders' equity | 239,828,000 | 78,065,000 | 62,693,000 | 50,672,000 | 34,639,000 |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.